Price target
7.280.00 0.00%
The 3 analysts offering 1 year price forecasts for C17 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 4 analysts giving stock ratings to C17 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
C17 EPS for the last quarter is −0.11 EUR despite the estimation of −0.13 EUR. In the next quarter EPS is expected to reach −0.11 EUR. Track more of CORVUS PHARMACEUTICALS INC financials and stay on top of what is up with the company.
In the next quarter CORVUS PHARMACEUTICALS INC revenue is expected to reach 0 EUR. Check out CORVUS PHARMACEUTICALS INC revenue and earnings and make informed decisions.
According to analysts, C17 price target is 7.28 EUR with a max estimate of 11.16 EUR and a min estimate of 3.25 EUR. Check if this forecast comes true in a year, meanwhile watch CORVUS PHARMACEUTICALS INC stock price chart and keep track of the current situation with C17 news and stock market news.